Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : VNV-041
| Cat. No. | VNV-041 |
| Description | These viruses are wild type human adenovirus serotype 14 particles which are replication-competent. This product is intended for research use only. |
| Storage | -80°C |
| Shipping | Dry ice |
Wild-type human adenovirus serotype 14 (HAdV-14) is a respiratory pathogen that can cause mild to severe infections, particularly in immunocompromised individuals or in crowded environments. The virus is primarily transmitted through respiratory droplets, direct contact with contaminated surfaces, or the fecal-oral route, reflecting its tropism for epithelial cells of the respiratory, gastrointestinal, and ocular tracts. After entering host cells, the virus binds to host cell receptors (such as CAR and integrins) via its fiber knob protein, promoting internalization and endosomal escape. Subsequent viral replication leads to cell lysis, triggering local inflammation and systemic immune responses. Severe cases may progress to pneumonia, acute respiratory distress syndrome (ARDS), and even multi-organ failure.
HAdV-14 is a non-enveloped, icosahedral virus approximately 90 nanometers in diameter. Its characteristic capsid is composed of 240 hexon trimers and 12 apex-located penton bases. Each trimer is anchored by a protruding fiber protein that is essential for host cell attachment. The double-stranded DNA genome (approximately 35 kb) contains tightly packed core proteins and encodes early (E1-E4) and intermediate (L1-L5) genes that regulate viral replication, immune evasion, and capsid assembly. Early genes regulate the host cell cycle (e.g., E1A inactivates tumor suppressors), while late genes produce structural components. The ends of the genome contain inverted terminal repeats (ITRs) essential for replication and packaging, as well as the virally encoded protease required for viral maturation. The genetic stability of HAdV-14 is occasionally compromised by recombination events, resulting in the emergence of new strains with altered pathogenicity.
Human adenovirus (HAdV) can cause severe respiratory symptoms in immunocompromised people, and there is currently no targeted treatment for adenovirus infection. Selenium (Se) plays an important role in antioxidation, redox signal transduction, and redox homeostasis. The excellent biological activity of selenium is mainly achieved through conversion to selenocystine (SeC). Selenium participates in the active sites of various selenoproteins in the form of SeC. In recent years, SeC has attracted much attention due to its unique antioxidant activity. The antiviral ability of SeC was determined by detecting the infection rate of the virus in cells. Here, researchers designed SeC to resist A549 cell infection caused by human adenovirus type 14 (HAdV-14). SeC can prevent DNA damage-related cell apoptosis caused by HAdV-14. SeC significantly inhibited the generation of ROS and protected cells from ROS-induced oxidative damage of HAdV-14. SeC induced the increase of antiviral cytokines such as IL-6 and IL-8 by activating the Jak2 signaling pathway and repaired DNA damage by inhibiting the ATR, p53, and PARP signaling pathways. Therefore, SeC may provide an effective selenium species with antiviral properties for the therapies against HAdV-14.
The apoptosis rates of the control group and the SeC-treated group were 2.7% and 5.0%, and the necrosis rates were 1.3% and 2.7%, respectively, while the apoptosis and necrosis rates of the virus group were 12.6% and 24.2%, respectively. After SeC treatment, the apoptosis and necrosis rates of A549 cells infected with HAdV-14 were significantly reduced, similar to those of the control group (Figure 1A). The changes in intracellular fluorescence were observed by fluorescence microscopy, which was consistent with the results of flow cytometry (Figure 1B). These results indicate that HAdV-14 infection causes the normal cell cycle of A549 cells to be disrupted, thereby mediating the cells to enter the apoptosis and necrosis stages. SeC can effectively alleviate the apoptosis and necrosis caused by HAdV-14 infection. A549 cells infected with HAdV-14 showed obvious nuclear deformation and DNA fragmentation, and DNA fragmentation mainly occurred in the nucleus. After SeC treatment, DNA fragmentation in the nucleus of A549 cells infected with HAdV-14 was significantly reduced (Figure 1C). In addition, compared with the control group, the TUNEL fluorescence intensity of the virus group increased significantly to 289.3%, while the fluorescence intensity of the Virus+SeC group decreased significantly to 137.1% (Figure 1D). These results indicate that SeC can prevent genomic DNA damage caused by HAdV-14.
Figure 1. Inhibitory effect of SeC on apoptosis and DNA fragmentation induced by HAdV-14 infection. (Zheng R, et al., 2023)
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
The Wild-Type Adenovirus (Serotype 14) was instrumental in our recent study. The virus was well-characterized, and the results were reproducible.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.